a Diagnoses: Cryptococcal meningitis (7), recurrent meningitis (1), systemic lupus erythematosus (1), cyclic fever (2), neuromyelitis optica (1), autoimmune lymphoproliferative syndrome-like disorder

NIAID Data Ecosystem50

Supplementary Table S5B from Clinical Activity and Exploratory Resistance Mechanism of Milademetan, an MDM2 Inhibitor, in Intimal Sarcoma with MDM2 Amplification: An Open-Label Phase Ib/II Study

肿瘤基因组学

治疗反应评估

Whole-exome sequencing and RNA sequencing analyses of tumor tissue samples at pre-and post-treatment

Figshare2023-08-04 更新00

Additional file 4 of Disulfidptosis-related signatures for prognostic and immunotherapy reactivity evaluation in hepatocellular carcinoma

肝细胞癌预后

治疗反应评估

Additional file 4: GSEA Analysis Results

Figshare2024-08-14 更新50

Demographic and clinical parameters in 40 inpatients suffering from unipolar depression treated with either reboxetine (n = 20; 8 mg/day) or mirtazapine (n = 20; 45 mg/day) for 5 weeks (sample 1) [33].

治疗反应评估

生物标志物分析

Mean±standard deviation (SD) is indicated. Patients are subdivided into COR week 1 Im (improvers)/COR peak NIm (nonimprovers) and into COR week 5 Im/NIm. COR peak week 1/week 5 Im ( = COR peak week 1/

NIAID Data Ecosystem30

EORTC metabolic response group definitions.

资源简介：

相关数据集